Johnson & Johnson has found a private equity firm willing to pay $4.15 billion for its Ortho Clinical Diagnostics division, which provides blood-testing equipment and chemicals. One would think that blood testing should be a booming ...
Tags: Get out of Blood Testing Tech, J&J